Neurones Statistics

Total Valuation

Neurones has a market cap or net worth of EUR 1.13 billion. The enterprise value is 905.96 million.

Market Cap	1.13B
Enterprise Value	905.96M

Important Dates

The next estimated earnings date is Wednesday, September 10, 2025.

Earnings Date	Sep 10, 2025
Ex-Dividend Date	Jun 11, 2025

Share Statistics

Neurones has 24.27 million shares outstanding. The number of shares has increased by 0.14% in one year.

Current Share Class	24.27M
Shares Outstanding	24.27M
Shares Change (YoY)	+0.14%
Shares Change (QoQ)	-0.02%
Owned by Insiders (%)	4.42%
Owned by Institutions (%)	13.44%
Float	23.20M

Valuation Ratios

The trailing PE ratio is 21.60 and the forward PE ratio is 21.25.

PE Ratio	21.60
Forward PE	21.25
PS Ratio	1.40
PB Ratio	2.60
P/TBV Ratio	3.54
P/FCF Ratio	15.65
P/OCF Ratio	13.42
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.53, with an EV/FCF ratio of 12.52.

EV / Earnings	17.24
EV / Sales	1.12
EV / EBITDA	9.53
EV / EBIT	11.64
EV / FCF	12.52

Financial Position

The company has a current ratio of 2.33, with a Debt / Equity ratio of 0.10.

Current Ratio	2.33
Quick Ratio	2.26
Debt / Equity	0.10
Debt / EBITDA	0.44
Debt / FCF	0.58
Interest Coverage	42.79

Financial Efficiency

Return on equity (ROE) is 14.95% and return on invested capital (ROIC) is 10.44%.

Return on Equity (ROE)	14.95%
Return on Assets (ROA)	6.94%
Return on Invested Capital (ROIC)	10.44%
Return on Capital Employed (ROCE)	16.45%
Revenue Per Employee	118,317
Profits Per Employee	7,674
Employee Count	6,749
Asset Turnover	1.16
Inventory Turnover	863.92

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.16% in the last 52 weeks. The beta is 0.58, so Neurones's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	-1.16%
50-Day Moving Average	46.80
200-Day Moving Average	45.65
Relative Strength Index (RSI)	51.89
Average Volume (20 Days)	7,828

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Neurones had revenue of EUR 810.35 million and earned 52.56 million in profits. Earnings per share was 2.16.

Revenue	810.35M
Gross Profit	388.76M
Operating Income	77.83M
Pretax Income	88.11M
Net Income	52.56M
EBITDA	86.92M
EBIT	77.83M
Earnings Per Share (EPS)	2.16

Full Income Statement

Balance Sheet

The company has 326.49 million in cash and 42.02 million in debt, giving a net cash position of 284.47 million or 11.72 per share.

Cash & Cash Equivalents	326.49M
Total Debt	42.02M
Net Cash	284.47M
Net Cash Per Share	11.72
Equity (Book Value)	436.17M
Book Value Per Share	15.58
Working Capital	335.46M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 84.38 million and capital expenditures -12.04 million, giving a free cash flow of 72.35 million.

Operating Cash Flow	84.38M
Capital Expenditures	-12.04M
Free Cash Flow	72.35M
FCF Per Share	2.98

Full Cash Flow Statement

Margins

Gross margin is 47.97%, with operating and profit margins of 9.60% and 6.49%.

Gross Margin	47.97%
Operating Margin	9.60%
Pretax Margin	10.87%
Profit Margin	6.49%
EBITDA Margin	10.73%
EBIT Margin	9.60%
FCF Margin	8.93%

Dividends & Yields

This stock pays an annual dividend of 1.30, which amounts to a dividend yield of 2.79%.

Dividend Per Share	1.30
Dividend Yield	2.79%
Dividend Growth (YoY)	8.33%
Years of Dividend Growth	2
Payout Ratio	55.42%
Buyback Yield	-0.14%
Shareholder Yield	2.62%
Earnings Yield	4.64%
FCF Yield	6.39%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Neurones has an Altman Z-Score of 4.36.

Altman Z-Score	4.36
Piotroski F-Score	n/a